25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Fredun Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyze Fredun Pharmaceuticals Ltd together

I guess you are interested in Fredun Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Fredun Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Fredun Pharmaceuticals Ltd

I send you an email if I find something interesting about Fredun Pharmaceuticals Ltd.

1. Quick Overview

1.1. Quick analysis of Fredun Pharmaceuticals Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Fredun Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR258.50
Expected worth in 1 year
INR441.90
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR183.41
Return On Investment
27.2%

For what price can you sell your share?

Current Price per Share
INR673.70
Expected price per share
INR682.58 - INR828.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Fredun Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)
INR673.70
Intrinsic Value Per Share
INR-382.57 - INR-89.54
Total Value Per Share
INR-124.07 - INR168.95

2.2. Growth of Fredun Pharmaceuticals Ltd (5 min.)




Is Fredun Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$14.3m$11.3m$2.9m20.7%

How much money is Fredun Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money$1.8m$1.2m$568.3k30.8%
Net Profit Margin4.5%3.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Fredun Pharmaceuticals Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Fredun Pharmaceuticals Ltd?

Welcome investor! Fredun Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Fredun Pharmaceuticals Ltd.

First you should know what it really means to hold a share of Fredun Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Fredun Pharmaceuticals Ltd is INR673.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fredun Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fredun Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR258.50. Based on the TTM, the Book Value Change Per Share is INR45.85 per quarter. Based on the YOY, the Book Value Change Per Share is INR59.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fredun Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.390.1%0.390.1%0.280.0%0.190.0%0.150.0%
Usd Book Value Change Per Share0.540.1%0.540.1%0.700.1%0.380.1%0.380.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.540.1%0.540.1%0.700.1%0.380.1%0.380.1%
Usd Price Per Share10.25-10.25-13.22-8.24-5.87-
Price to Earnings Ratio26.13-26.13-46.98-53.07-40.44-
Price-to-Total Gains Ratio18.95-18.95-18.95-38.77-26.08-
Price to Book Ratio3.36-3.36-5.27-4.07-3.36-
Price-to-Total Gains Ratio18.95-18.95-18.95-38.77-26.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.94966
Number of shares125
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.540.38
Usd Total Gains Per Share0.540.38
Gains per Quarter (125 shares)67.6347.43
Gains per Year (125 shares)270.53189.71
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102712610190180
205415320379370
308128030569560
40108210740759750
50135313450949940
6016231616011381130
7018941887013281320
8021642158015181510
9024352429017071700
10027052700018971890

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Fredun Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--45.85245.8520%59.099-22%32.154+43%32.312+42%
Book Value Per Share--258.495258.4950%212.643+22%167.242+55%128.688+101%
Current Ratio--1.5421.5420%2.037-24%1.691-9%1.484+4%
Debt To Asset Ratio--0.6050.6050%0.625-3%0.662-9%0.691-12%
Debt To Equity Ratio--1.5321.5320%1.670-8%2.025-24%2.640-42%
Dividend Per Share----0%-0%-0%-0%
Eps--33.24733.2470%23.844+39%16.240+105%12.945+157%
Free Cash Flow Per Share---17.190-17.1900%-52.740+207%-23.682+38%-16.883-2%
Free Cash Flow To Equity Per Share---17.190-17.1900%2.809-712%-2.678-84%-4.085-76%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---89.543--------
Intrinsic Value_10Y_min---382.565--------
Intrinsic Value_1Y_max---20.557--------
Intrinsic Value_1Y_min---31.156--------
Intrinsic Value_3Y_max---52.938--------
Intrinsic Value_3Y_min---100.384--------
Intrinsic Value_5Y_max---74.675--------
Intrinsic Value_5Y_min---176.505--------
Market Cap--4082396987.5004082396987.5000%5077048854.000-20%3107144571.840+31%2168333504.950+88%
Net Profit Margin--0.0450.0450%0.039+14%0.029+55%0.031+46%
Operating Margin----0%-0%0.009-100%0.030-100%
Operating Ratio--1.6951.6950%1025.802-100%206.547-99%129.460-99%
Pb Ratio2.606-29%3.3613.3610%5.268-36%4.065-17%3.361+0%
Pe Ratio20.263-29%26.13026.1300%46.981-44%53.069-51%40.440-35%
Price Per Share673.700-29%868.750868.7500%1120.200-22%698.650+24%497.613+75%
Price To Free Cash Flow Ratio-39.192+22%-50.538-50.5380%-21.240-58%-55.492+10%-36.038-29%
Price To Total Gains Ratio14.693-29%18.94718.9470%18.9550%38.766-51%26.077-27%
Quick Ratio--0.3950.3950%0.599-34%0.694-43%0.707-44%
Return On Assets--0.0510.0510%0.042+21%0.031+66%0.030+67%
Return On Equity--0.1290.1290%0.112+15%0.085+51%0.102+26%
Total Gains Per Share--45.85245.8520%59.099-22%32.154+43%32.312+42%
Usd Book Value--14333601.60014333601.6000%11372332.600+26%8739057.297+64%6470986.793+122%
Usd Book Value Change Per Share--0.5410.5410%0.697-22%0.379+43%0.381+42%
Usd Book Value Per Share--3.0503.0500%2.509+22%1.973+55%1.519+101%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.3920.3920%0.281+39%0.192+105%0.153+157%
Usd Free Cash Flow---953180.400-953180.4000%-2820601.200+196%-1226927.989+29%-854431.666-10%
Usd Free Cash Flow Per Share---0.203-0.2030%-0.622+207%-0.279+38%-0.199-2%
Usd Free Cash Flow To Equity Per Share---0.203-0.2030%0.033-712%-0.032-84%-0.048-76%
Usd Market Cap--48172284.45348172284.4530%59909176.477-20%36664305.948+31%25586335.358+88%
Usd Price Per Share7.950-29%10.25110.2510%13.218-22%8.244+24%5.872+75%
Usd Profit--1843561.2001843561.2000%1275178.800+45%865692.439+113%653723.938+182%
Usd Revenue--40896074.20040896074.2000%32372320.600+26%25653040.417+59%19146581.986+114%
Usd Total Gains Per Share--0.5410.5410%0.697-22%0.379+43%0.381+42%
 EOD+3 -3MRQTTM+0 -0YOY+20 -125Y+25 -810Y+23 -10

3.3 Fundamental Score

Let's check the fundamental score of Fredun Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.263
Price to Book Ratio (EOD)Between0-12.606
Net Profit Margin (MRQ)Greater than00.045
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.395
Current Ratio (MRQ)Greater than11.542
Debt to Asset Ratio (MRQ)Less than10.605
Debt to Equity Ratio (MRQ)Less than11.532
Return on Equity (MRQ)Greater than0.150.129
Return on Assets (MRQ)Greater than0.050.051
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Fredun Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.899
Ma 20Greater thanMa 50705.663
Ma 50Greater thanMa 100746.274
Ma 100Greater thanMa 200784.777
OpenGreater thanClose675.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Fredun Pharmaceuticals Ltd

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Fredun Pharmaceuticals Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Fredun Pharmaceuticals Ltd to the  industry mean.
  • A Net Profit Margin of 4.5% means that ₹0.05 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fredun Pharmaceuticals Ltd:

  • The MRQ is 4.5%. The company is making a profit. +1
  • The TTM is 4.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.5%TTM4.5%0.0%
TTM4.5%YOY3.9%+0.6%
TTM4.5%5Y2.9%+1.6%
5Y2.9%10Y3.1%-0.2%
4.3.1.2. Return on Assets

Shows how efficient Fredun Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fredun Pharmaceuticals Ltd to the  industry mean.
  • 5.1% Return on Assets means that Fredun Pharmaceuticals Ltd generated ₹0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fredun Pharmaceuticals Ltd:

  • The MRQ is 5.1%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.1%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.1%TTM5.1%0.0%
TTM5.1%YOY4.2%+0.9%
TTM5.1%5Y3.1%+2.0%
5Y3.1%10Y3.0%+0.0%
4.3.1.3. Return on Equity

Shows how efficient Fredun Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fredun Pharmaceuticals Ltd to the  industry mean.
  • 12.9% Return on Equity means Fredun Pharmaceuticals Ltd generated ₹0.13 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fredun Pharmaceuticals Ltd:

  • The MRQ is 12.9%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 12.9%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ12.9%TTM12.9%0.0%
TTM12.9%YOY11.2%+1.6%
TTM12.9%5Y8.5%+4.3%
5Y8.5%10Y10.2%-1.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Fredun Pharmaceuticals Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Fredun Pharmaceuticals Ltd is operating .

  • Measures how much profit Fredun Pharmaceuticals Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fredun Pharmaceuticals Ltd to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fredun Pharmaceuticals Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y0.9%-0.9%
5Y0.9%10Y3.0%-2.1%
4.3.2.2. Operating Ratio

Measures how efficient Fredun Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.69 means that the operating costs are ₹1.69 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Fredun Pharmaceuticals Ltd:

  • The MRQ is 1.695. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.695. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.695TTM1.6950.000
TTM1.695YOY1,025.802-1,024.108
TTM1.6955Y206.547-204.852
5Y206.54710Y129.460+77.086
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Fredun Pharmaceuticals Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Fredun Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.54 means the company has ₹1.54 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Fredun Pharmaceuticals Ltd:

  • The MRQ is 1.542. The company is able to pay all its short-term debts. +1
  • The TTM is 1.542. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.542TTM1.5420.000
TTM1.542YOY2.037-0.495
TTM1.5425Y1.691-0.149
5Y1.69110Y1.484+0.206
4.4.3.2. Quick Ratio

Measures if Fredun Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fredun Pharmaceuticals Ltd to the  industry mean.
  • A Quick Ratio of 0.40 means the company can pay off ₹0.40 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fredun Pharmaceuticals Ltd:

  • The MRQ is 0.395. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.395. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.395TTM0.3950.000
TTM0.395YOY0.599-0.204
TTM0.3955Y0.694-0.299
5Y0.69410Y0.707-0.014
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Fredun Pharmaceuticals Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Fredun Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fredun Pharmaceuticals Ltd to industry mean.
  • A Debt to Asset Ratio of 0.61 means that Fredun Pharmaceuticals Ltd assets are financed with 60.5% credit (debt) and the remaining percentage (100% - 60.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fredun Pharmaceuticals Ltd:

  • The MRQ is 0.605. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.605. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.605TTM0.6050.000
TTM0.605YOY0.625-0.020
TTM0.6055Y0.662-0.056
5Y0.66210Y0.691-0.029
4.5.4.2. Debt to Equity Ratio

Measures if Fredun Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fredun Pharmaceuticals Ltd to the  industry mean.
  • A Debt to Equity ratio of 153.2% means that company has ₹1.53 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fredun Pharmaceuticals Ltd:

  • The MRQ is 1.532. The company is just able to pay all its debts with equity.
  • The TTM is 1.532. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.532TTM1.5320.000
TTM1.532YOY1.670-0.137
TTM1.5325Y2.025-0.492
5Y2.02510Y2.640-0.615
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Fredun Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Fredun Pharmaceuticals Ltd to the  industry mean.
  • A PE ratio of 26.13 means the investor is paying ₹26.13 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fredun Pharmaceuticals Ltd:

  • The EOD is 20.263. Based on the earnings, the company is fair priced.
  • The MRQ is 26.130. Based on the earnings, the company is overpriced. -1
  • The TTM is 26.130. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD20.263MRQ26.130-5.867
MRQ26.130TTM26.1300.000
TTM26.130YOY46.981-20.851
TTM26.1305Y53.069-26.939
5Y53.06910Y40.440+12.628
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fredun Pharmaceuticals Ltd:

  • The EOD is -39.192. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -50.538. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -50.538. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-39.192MRQ-50.538+11.347
MRQ-50.538TTM-50.5380.000
TTM-50.538YOY-21.240-29.299
TTM-50.5385Y-55.492+4.953
5Y-55.49210Y-36.038-19.454
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Fredun Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 3.36 means the investor is paying ₹3.36 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Fredun Pharmaceuticals Ltd:

  • The EOD is 2.606. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.361. Based on the equity, the company is fair priced.
  • The TTM is 3.361. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.606MRQ3.361-0.755
MRQ3.361TTM3.3610.000
TTM3.361YOY5.268-1.907
TTM3.3615Y4.065-0.704
5Y4.06510Y3.361+0.704
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets3,075,991
Total Liabilities1,861,279
Total Stockholder Equity1,214,712
 As reported
Total Liabilities 1,861,279
Total Stockholder Equity+ 1,214,712
Total Assets = 3,075,991

Assets

Total Assets3,075,991
Total Current Assets2,571,995
Long-term Assets503,997
Total Current Assets
Cash And Cash Equivalents 10,717
Short-term Investments 10,488
Net Receivables 648,488
Inventory 1,749,980
Other Current Assets 14,389
Total Current Assets  (as reported)2,571,995
Total Current Assets  (calculated)2,434,062
+/- 137,933
Long-term Assets
Property Plant Equipment 461,529
Intangible Assets 4,195
Long-term Assets Other 2
Long-term Assets  (as reported)503,997
Long-term Assets  (calculated)465,726
+/- 38,271

Liabilities & Shareholders' Equity

Total Current Liabilities1,668,275
Long-term Liabilities193,004
Total Stockholder Equity1,214,712
Total Current Liabilities
Short Long Term Debt 927,119
Accounts payable 629,469
Total Current Liabilities  (as reported)1,668,275
Total Current Liabilities  (calculated)1,556,588
+/- 111,687
Long-term Liabilities
Long term Debt 127,981
Long-term Liabilities  (as reported)193,004
Long-term Liabilities  (calculated)127,981
+/- 65,023
Total Stockholder Equity
Retained Earnings 437,732
Total Stockholder Equity (as reported)1,214,712
Total Stockholder Equity (calculated)437,732
+/- 776,980
Other
Capital Stock46,992
Common Stock Shares Outstanding 4,699
Net Debt 1,044,383
Net Invested Capital 2,269,812
Net Working Capital 903,720
Property Plant and Equipment Gross 622,983



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
560,978
792,649
1,049,096
1,413,781
1,616,185
1,869,887
2,572,795
3,075,991
3,075,9912,572,7951,869,8871,616,1851,413,7811,049,096792,649560,978
   > Total Current Assets 
352,436
514,802
725,192
1,011,091
1,300,810
1,526,496
2,162,111
2,571,995
2,571,9952,162,1111,526,4961,300,8101,011,091725,192514,802352,436
       Cash And Cash Equivalents 
0
0
14,667
27,526
11,282
20,718
34,351
10,717
10,71734,35120,71811,28227,52614,66700
       Short-term Investments 
0
77,700
30
20,837
8,508
8,163
128,146
10,488
10,488128,1468,1638,50820,8373077,7000
       Net Receivables 
262,230
236,017
296,016
465,347
410,753
902,732
345,603
648,488
648,488345,603902,732410,753465,347296,016236,017262,230
       Inventory 
69,366
184,254
407,801
504,617
675,745
464,602
1,501,236
1,749,980
1,749,9801,501,236464,602675,745504,617407,801184,25469,366
       Other Current Assets 
10,136
79,998
7,080
10,185
187,084
129,229
151,270
14,389
14,389151,270129,229187,08410,1857,08079,99810,136
   > Long-term Assets 
0
0
323,903
320,547
315,374
343,391
4
503,997
503,9974343,391315,374320,547323,90300
       Property Plant Equipment 
204,618
274,069
313,264
309,266
303,247
322,826
4
461,529
461,5294322,826303,247309,266313,264274,069204,618
       Intangible Assets 
0
0
0
412
272
558
3,078
4,195
4,1953,078558272412000
       Long-term Assets Other 
0
0
0
0
0
-2
0
2
20-200000
> Total Liabilities 
488,377
571,022
659,203
1,000,568
1,185,483
1,189,281
1,609,038
1,861,279
1,861,2791,609,0381,189,2811,185,4831,000,568659,203571,022488,377
   > Total Current Liabilities 
404,693
431,419
534,059
777,750
864,559
737,504
1,061,679
1,668,275
1,668,2751,061,679737,504864,559777,750534,059431,419404,693
       Short-term Debt 
0
0
86,319
234,064
105,295
107,250
375,963
0
0375,963107,250105,295234,06486,31900
       Short Long Term Debt 
0
0
96,946
283,311
167,372
186,192
4
927,119
927,1194186,192167,372283,31196,94600
       Accounts payable 
228,274
389,209
337,044
441,885
599,606
486,167
6
629,469
629,4696486,167599,606441,885337,044389,209228,274
       Other Current Liabilities 
55,094
35,603
34,876
38,898
1
115,925
-1
0
0-1115,925138,89834,87635,60355,094
   > Long-term Liabilities 
0
0
277,444
140,674
320,924
451,777
10
193,004
193,00410451,777320,924140,674277,44400
       Long term Debt Total 
72,391
0
106,391
114,958
291,108
420,394
489,287
0
0489,287420,394291,108114,958106,391072,391
       Long-term Liabilities Other 
0
0
69,588
0
0
0
-38,425
0
0-38,42500069,58800
> Total Stockholder Equity
72,600
221,627
389,892
413,213
430,702
680,606
963,757
1,214,712
1,214,712963,757680,606430,702413,213389,892221,62772,600
   Common Stock
23,524
34,251
39,896
39,896
311,447
498,441
595,009
0
0595,009498,441311,44739,89639,89634,25123,524
   Retained Earnings 
23,855
36,971
78,445
101,766
119,255
182,165
368,749
437,732
437,732368,749182,165119,255101,76678,44536,97123,855
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
222
222
0
0
0
0
-1
0
0-10000222222



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,465,769
Cost of Revenue-2,749,402
Gross Profit716,367716,367
 
Operating Income (+$)
Gross Profit716,367
Operating Expense-3,123,905
Operating Income341,864-2,407,538
 
Operating Expense (+$)
Research Development67
Selling General Administrative1,000
Selling And Marketing Expenses0
Operating Expense3,123,9051,067
 
Net Interest Income (+$)
Interest Income0
Interest Expense-136,501
Other Finance Cost-0
Net Interest Income-136,501
 
Pretax Income (+$)
Operating Income341,864
Net Interest Income-136,501
Other Non-Operating Income Expenses0
Income Before Tax (EBT)214,519341,864
EBIT - interestExpense = -136,501
156,234
292,735
Interest Expense136,501
Earnings Before Interest and Taxes (EBIT)0351,020
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax214,519
Tax Provision-58,285
Net Income From Continuing Ops156,234156,234
Net Income156,234
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0136,501
 

Technical Analysis of Fredun Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Fredun Pharmaceuticals Ltd. The general trend of Fredun Pharmaceuticals Ltd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Fredun Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Fredun Pharmaceuticals Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 716.65 < 780.14 < 828.00.

The bearish price targets are: 682.58.

Tweet this
Fredun Pharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Fredun Pharmaceuticals Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Fredun Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Fredun Pharmaceuticals Ltd. The current macd is -19.69008606.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Fredun Pharmaceuticals Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Fredun Pharmaceuticals Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Fredun Pharmaceuticals Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Fredun Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartFredun Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Fredun Pharmaceuticals Ltd. The current adx is 18.12.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Fredun Pharmaceuticals Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Fredun Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Fredun Pharmaceuticals Ltd. The current sar is 797.07.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Fredun Pharmaceuticals Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Fredun Pharmaceuticals Ltd. The current rsi is 34.90. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Fredun Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartFredun Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Fredun Pharmaceuticals Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Fredun Pharmaceuticals Ltd price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Fredun Pharmaceuticals Ltd Daily Stochastic Oscillator ChartFredun Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Fredun Pharmaceuticals Ltd. The current cci is -167.40684144.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Fredun Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartFredun Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Fredun Pharmaceuticals Ltd. The current cmo is -34.84587243.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Fredun Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartFredun Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Fredun Pharmaceuticals Ltd. The current willr is -87.09454796.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Fredun Pharmaceuticals Ltd Daily Williams %R ChartFredun Pharmaceuticals Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Fredun Pharmaceuticals Ltd.

Fredun Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Fredun Pharmaceuticals Ltd. The current atr is 37.30.

Fredun Pharmaceuticals Ltd Daily Average True Range (ATR) ChartFredun Pharmaceuticals Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Fredun Pharmaceuticals Ltd. The current obv is 109,545.

Fredun Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartFredun Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Fredun Pharmaceuticals Ltd. The current mfi is 35.29.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Fredun Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartFredun Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Fredun Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-11-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Fredun Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Fredun Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.899
Ma 20Greater thanMa 50705.663
Ma 50Greater thanMa 100746.274
Ma 100Greater thanMa 200784.777
OpenGreater thanClose675.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Fredun Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on Fredun Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Fredun Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Fredun Pharmaceuticals Ltd

I send you an email if I find something interesting about Fredun Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Fredun Pharmaceuticals Ltd.

Receive notifications about Fredun Pharmaceuticals Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.